Post-Infusion CAR T Regulatory Cells Identify Patients With LBCL Resistant to CD19-CAR Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy
Nat. Med. 2022 Sep 12;28(9)1860-1871, Z Good, JY Spiegel, B Sahaf, MB Malipatlolla, ZJ Ehlinger, S Kurra, MH Desai, WD Reynolds, A Wong Lin, P Vandris, F Wu, S Prabhu, MP Hamilton, JS Tamaresis, PJ Hanson, S Patel, SA Feldman, MJ Frank, JH Baird, L Muffly, GK Claire, J Craig, KA Kong, D Wagh, J Coller, SC Bendall, RJ Tibshirani, SK Plevritis, DB Miklos, CL MackallFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.